EFFECT OF VITAMIN D SUPPLEMENTATION ON INSULIN SENSITIVITY AND ANDROGEN LEVEL IN VITAMIN D-DEFICIENT POLYCYSTIC OVARY SYNDROME PATIENTS

Authors

  • Saba M Swadi Al-thuwaynee Department of Obstetrics and Gynecology, College of Medicine, University of Al-Qadisiyah, Iraq.
  • Amaal Raad Ahmed Department of Family Medicine, Al- Dewaniyah Teaching Hospital, Al-Diwaniyah, Iraq.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i12.29036

Keywords:

Polycystic ovary syndrome, Vitamin D, Impaired glucose tolerance

Abstract

Objectives: There is limited evidence that giving Vitamin D supplementation had a beneficial effect on insulin resistance and dysfunction of the menstrual cycle in females with polycystic ovary syndrome (PCOS). Thus, the aim of the present study is to evaluate the effect of Vitamin D supplementation on insulin sensitivity and androgen level in Iraqi females with PCOS.

Methods: A randomized, blinded clinical trial design studied 60 Iraqi females with PCOS referring to the women's counseling, outpatients at maternity and pediatrics teaching hospital in AL-Qadisiyah city, Iraq, and private clinic. Non-probabilistic sampling involved women aged from 18 to 45 years established on inclusion criteria. The patients' basic data have been recorded. Then, we measured Vitamin D, testosterone level, and impaired glucose tolerance (IGT) test to all females. After the diagnosis of Vitamin D deficiency, Vitamin D was administering at 5000 units daily for 8 weeks. All data were remeasured after 2 months.

Result: A total of 60 patients with polycystic syndrome enrolled in the study, age range from 18 to 39 years, mean age 27.48±5.95 years. The metabolic parameter have been checked at the beginning of the study, which include Vitamin D level 16.1±5.6, impaired glucose test reading 8.8±0.7 and testosterone level 4.5±0.64.. After 2 months of supplementation, there were 83.7% of patients reach the normal level of Vitamin D and 16.3% still had a low level of Vitamin D (p≤0.002) between two groups. In regard to IGT test after 2 months of supplementation, there were 51.6% of patients still who had impaired test while 48.4% reach the normal reading (p≤0.001).

Conclusions: Women with PCOS have a statically significant low level of Vitamin D in mean, IGT test in the mean, and high level of testosterone, and there were inverse correlations between Vitamin D with IGT and testosterone.

Downloads

Download data is not yet available.

References

Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, et al. The polycystic ovary syndrome: A position statement from the European society of endocrinology. Eur J Endocrinol 2014;171:1-29.

Krul YH, Snackey C, Louwers Y. The role of Vitamin D in metabolic disturbances in PCOS. Eur J Endocrinol 2013;169:853-65.

Rahimi-Ardabili H, Gargari BP, Farzadi L. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and Vitamin D deficiency. Nutr Res 2012;3:195-201.

Thomson RL, Spedding S, Brinkworth GD, Noakes M, Buckley JD. Seasonal effects on Vitamin D status influence outcomes of lifestyle intervention in overweight and obese women with polycystic ovary syndrome. Fertil Steril 2013;99:1779-85.

Faraji R, Sharami SH, Zahiri Z, Asgharni M, Kazemnejad E, Sadeghi S. Evaluation of relation between anthropometric indices and Vitamin D concentrations in women with polycystic ovarian syndrome. J Family Reprod Health 2014;8:123-9.

Bergiota A, Diamanti-Kandarakis E. The effect of old, new and emerging medicines on metabolic aberrations in PCOS. Ther Adv Endocrinol Metab 2012;1:27-47.

Banuls C, Rovira-Llopis S, Martinez de Maranon A, Veses S, Jover A, Gomez M, et al. Metabolic syndrome enhances endoplasmic reticulum, oxidative stress and leukocyte-endothelium interactions in PCOS. Metabolism 2017;71:153-62.

Li HW, Breteton RE, Anderson RA, Wallace AM, Ho CK. Vitamin D deficiency is common and associated with metabolic risk factors in pateints with polycystic ovary syndrome. Metabolism 2011;60:1475-81.

Gallea M, Granzotto M, Azzolini S, Faggian D, Mozzanega B, Vettor R, et al. Insulin and bodyweight but not hyperandrogenism seem involved in seasonal serum 25-OH-Vitamin D3 levels in subjects affected by PCOS. Gynecol Endocrinol 2014;30:739-45.

Hahn S, Haselhorst U, Tan S, Quadbeck B, Schmidt M, Roesler S, et al.Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2006;114:577-83.

Tzotzas T, Papadopoulou FG, Tziomalos K, Karras S, Gastaris K, Perros P, et al. Rising serum 25-hydroxy-Vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance.J Clin Endocrinol Metab 2010;95:4251-7.

Mm AA, Alias A, Sajith M, Nimbargi V, Kumdale S. Prescription pattern in obese and non-obese infertile women with polycystic ovary syndrome in a tertiary care hospital. Asian J Pharm Clin Res 2018;11:53-6.

Garg G, Kachhawa G, Ramot R, Khadgawat R, Tandon N, Sreenivas V, et al. Effect of Vitamin D supplementation on insulin kinetics and cardiovascular risk factors in polycystic ovarian syndrome: A pilot study. Endocr Connect 2015;4:108-16.

Raja-Khan N, Shah J, Stetter CM, Lott ME, Kunselman AR, Dodson WC, et al. High dose Vitamin D supplementation and measures of insulin sensitivity in polycystic ovarian syndrome. Fertile Steril 2014;101:1740-6.

He C, Lin Z, Robb SW, Ezeamama AE. Serum Vitamin D levels and polycystic ovary syndrome: A systematic review and meta-analysis. Nutrients 2015;7:4555-77.

Kataria J, Gill GK, Kaur M. Interrelationship of thyroid hormones, obesity, and prolactin in infertile women. Asian J Pharm Clin Res 2018;11:136-7.

Ardabili HR, Gargari BP, Farzadi L. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Nutr Res 2012;32:195-201.

Fang F, Ni K, Cai Y, Shang J, Zhang X, Xiong C. Effect of Vitamin D supplementation on polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Clin Pract 2017;26:53-60.

Mahmoudi T, Gourabi H, Ashrafi M, Yazdi RS, Ezabadi Z. Calciotropic hormones, insulin resistance, and the polycysticovary syndrome. Fertil Steril 2010;93:1208-14.

Published

07-12-2018

How to Cite

Al-thuwaynee, S. M. S., and A. R. Ahmed. “EFFECT OF VITAMIN D SUPPLEMENTATION ON INSULIN SENSITIVITY AND ANDROGEN LEVEL IN VITAMIN D-DEFICIENT POLYCYSTIC OVARY SYNDROME PATIENTS”. Asian Journal of Pharmaceutical and Clinical Research, vol. 11, no. 12, Dec. 2018, pp. 456-8, doi:10.22159/ajpcr.2018.v11i12.29036.

Issue

Section

Original Article(s)